Literature DB >> 2222942

Effects of n-3 fatty acids in essential hypertension.

P D Levinson1, A H Iosiphidis, A L Saritelli, P N Herbert, M Steiner.   

Abstract

We examined the effects on blood pressure, plasma lipoproteins, and platelet function when marine oil supplements (rich in n-3 fatty acids) or vegetable oil supplements (rich in n-6 fatty acids) were added to the usual diets of patients with mild essential hypertension. In a randomized, double-blind, parallel-group study, patients received 50 g of either marine oil (n = 8) or vegetable oil (n = 8) daily for 6 weeks following a baseline observation period. Diastolic blood pressure declined during treatment with fish oil (mean +/- SEM, 96 +/- 2 v 89 +/- 2 mm Hg, P = .02), but did not change with vegetable oil (92 +/- 1 v 94 +/- 1 mm Hg). Systolic blood pressure did not change significantly during either treatment. Serum triglycerides declined (by approximately 30%) in patients receiving only marine oil, but total cholesterol, LDL-, HDL-, HDL2-, and HDL3-cholesterol-subfractions and apolipoproteins A-I and B were unchanged in both treatment groups. Bleeding time increased by 33% during treatment with marine oil but did not change with vegetable oil supplements. Marine oil did not alter in vitro platelet aggregation thresholds. The lack of a significant correlation between blood pressure changes and platelet membrane fluidity, plasma renin activity, aldosterone, norepinephrine, or epinephrine suggests that these variables did not mediate the antihypertensive effect of the marine oil. We conclude that large doses of marine oil reduce diastolic blood pressure, lower triglycerides, and increase bleeding time in patients with mild hypertension.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2222942     DOI: 10.1093/ajh/3.10.754

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

Review 1.  Omega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials.

Authors:  Xin Zhang; Jennifer A Ritonja; Na Zhou; Bingshu E Chen; Xinzhi Li
Journal:  J Am Heart Assoc       Date:  2022-06-01       Impact factor: 6.106

2.  Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.

Authors:  Arzu Ulu; Todd R Harris; Christophe Morisseau; Christina Miyabe; Hiromi Inoue; Gertrud Schuster; Hua Dong; Ana-Maria Iosif; Jun-Yan Liu; Robert H Weiss; Nipavan Chiamvimonvat; John D Imig; Bruce D Hammock
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

3.  Transgenic expression of n-3 fatty acid desaturase (fat-1) in C57/BL6 mice: Effects on glucose homeostasis and body weight.

Authors:  Shaonin Ji; Robert W Hardy; Philip A Wood
Journal:  J Cell Biochem       Date:  2009-07-01       Impact factor: 4.429

Review 4.  Omega-3 fatty acids. Current status in cardiovascular medicine.

Authors:  E B Schmidt; J Dyerberg
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

5.  Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials.

Authors:  Paige E Miller; Mary Van Elswyk; Dominik D Alexander
Journal:  Am J Hypertens       Date:  2014-03-06       Impact factor: 2.689

Review 6.  Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview.

Authors:  Lotte Smolders; Jogchum Plat; Ronald P Mensink
Journal:  J Nutr Metab       Date:  2017-06-12

7.  Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.

Authors:  Khemayanto Hidayat; Jing Yang; Zheng Zhang; Guo-Chong Chen; Li-Qiang Qin; Manfred Eggersdorfer; Weiguo Zhang
Journal:  Eur J Clin Nutr       Date:  2017-12-28       Impact factor: 4.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.